Results 11 to 20 of about 1,604 (182)

Digital Surveillance After Allogeneic Hematopoietic Stem Cell Transplantation Guides Therapeutic Interventions to Reduce Non-Relapse Mortality. [PDF]

open access: yesEur J Haematol
ABSTRACT Introduction Allogeneic hematopoietic stem cell transplantation (HSCT) offers curative potential for many hematological malignancies; however, outcomes may be adversely affected by infections and transplant‐associated complications, contributing to non‐relapse mortality (NRM).
Bischof L   +17 more
europepmc   +2 more sources

A cost-effectiveness analysis of breast cancer treatment in certified versus non-certified hospitals in Germany. [PDF]

open access: yesInt J Cancer
What's New? This study is the first to quantify the cost‐effectiveness of breast cancer treatment in German Cancer Society‐certified hospitals using real‐world data from over 140,000 patients. Analysis on certification‐related costs and survival outcomes demonstrates that high‐quality multidisciplinary care at certified hospitals delivers substantial ...
Lwin MW   +20 more
europepmc   +2 more sources

Interrupted Time Series Analysis of Alcohol Use Disorder Treatment Utilisation During the Coronavirus Pandemic in Hamburg, Germany. [PDF]

open access: yesDrug Alcohol Rev
ABSTRACT Introduction Alcohol use and treatment for alcohol use disorder (AUD) changed during the pandemic. Alcohol consumption increased among high‐risk groups, while treatment utilisation declined, raising concerns about an expanding treatment gap. This study analyses inpatient and outpatient AUD treatment trends during the pandemic.
Manthey J   +4 more
europepmc   +2 more sources

Around the Tables – Contextual Factors in Healthcare Coverage Decisions Across Western Europe [PDF]

open access: yesInternational Journal of Health Policy and Management, 2020
Background Across Western Europe, procedures and formalised criteria for taking decisions on the coverage (inclusion in the benefits basket or equivalent) of healthcare technologies vary substantially.
Tineke Kleinhout-Vliek   +6 more
doaj   +1 more source

Gesundheitssystem neu denken: Strategiewechsel jetzt! Teil 2

open access: yesMonitor Versorgungsforschung, 2021
Kommentar von Dr. Dr. Klaus Piwernetz (medimaxx health management GmbH, München ) und Univ.-Prof. Dr. Dr. h.c. Edmund A. M. Neugebauer (Präsident der Medizinischen Hochschule Brandenburg).
Dr. Dr. Klaus Piwernetz   +1 more
doaj   +1 more source

Änderungen der zweckmäßigen Vergleichstherapie

open access: yesMonitor Versorgungsforschung, 2022
Die Festlegung der zweckmäßigen Vergleichstherapie (zVT) ist eine zentrale Komponente der AMNOG-Nutzenbewertung und ist entscheidend für die Bewertung des Zusatznutzens eines neuen Arzneimittels.
Dr. PH Andrej Rasch
doaj   +1 more source

Disruptive technologies in health care disenchanted: A systematic review of concepts and examples [PDF]

open access: yes, 2022
Objectives To clarify the concept of disruptive technologies in health care, provide examples and consider implications of potentially disruptive technologies for health technology assessment (HTA).
Myles, Susan   +9 more
core   +1 more source

Implikation von Datenschnitten und Zensierung in klinischen Studien auf die Bewertbarkeit von Arzneimitteln

open access: yesMonitor Versorgungsforschung, 2021
Kommentar von Dr. PH Dipl.-Stat. Carsten Schwenke (SCO:SSiS Statistical Consulting, Berlin).
Dr. PH Dipl.-Stat. Carsten Schwenke
doaj   +1 more source

Competence-based catalog of learning objectives for the subject area of quality management in medical studies – position paper of the working group Quality Management in Education, Training and Continuing Education of the Society for Quality Management in Health Care (GQMG)

open access: yesGMS Journal for Medical Education, 2023
Background: Traditionally, direct medical competences are taught in medical studies, whereas leadership and quality management competences are hardly taught, although graduates are already confronted with management tasks at the beginning of their ...
Vogeser, Michael   +7 more
doaj   +1 more source

Die „Target Trial Emulation“ zu CAR-T im AMNOG

open access: yesMonitor Versorgungsforschung, 2023
Das Konzept „Target Trial Emulation“ sowie propensity score-basierte Adjustierungsverfahren sind empfohlene Methoden, um in indirekten Vergleichen ohne Brückenkomparator systematische Verzerrung zu minimieren. Anhand des Vergleichs der einarmigen Evidenz
Janine Jakobs BS MS   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy